Participants 66 106 5
adolescent HIV prevention trial in Kenya
Participants 643 760 7
837 Kenyan orphan youth in grades 7 and 8 enrolled in an HIV prevention clinical trial with HSV-2 biomarker outcomes.
Participants 1061 1142 3
28 adolescents (3.3%) were identified as HSV-2 seropositive, six as indeterminate
